The Center works with Texas’ Health and Human Services Commission (HHSC) to improve health outcomes for Texas’ most vulnerable populations.
The Idaho Medicaid Pharmacy Program launched a robust academic detailing program in response to wide variations in prescribing patterns for atypical antipsychotic medications — including increased prescribing rates for children. As part of this effort, pharmacists visited clinicians to discuss prescribing these medications.
The Center’s Drug Effectiveness Review Project (DERP) supported this program by creating an evidence-based guide for clinicians featuring FDA approved indications, “off-label” uses, side effect profiles, and potential drug-drug interactions for these medications. This user-friendly, easy-to-read resource also includes patient case studies and a behavioral health management algorithm.
Partner with the Center and do more for the good of all.